title: Use of autologous serum eyedrops for the treatment of ocular surface disease: first US experience in a large population as an insurance-covered benefit.
authors.forename: Cyril A
authors.initials: CA
authors.lastname: Dalmon
authors.forename: Naveen S
authors.initials: NS
authors.lastname: Chandra
authors.forename: Bennie H
authors.initials: BH
authors.lastname: Jeng
mesh_terms: D000368:Aged; D001804:Blood Transfusion, Autologous; D005128:Eye Diseases / Q000097:blood / Q000628:therapy*; D005260:Female; D006801:Humans; D007342:Insurance Benefits; D008297:Male; D009883:Ophthalmic Solutions; D012189:Retrospective Studies; D014481:United States
chemical_list: D009883:Ophthalmic Solutions